DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Eckman MH, Ward JW, Sherman KE.
Cost effectiveness of universal screening for hepatitis C virus infection in the era of direct-acting, pangenotypic treatment regimens.
Clin Gastroenterol Hepatol 2019;
17 (05) 930-939.e9
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.